Close Menu

MARCO ISLAND, Florida – Targeted transcriptomics, a new capability teased last week by 10x Genomics, will be available by the end of 2020, the company announced at the Advances in Genome Biology and Technology meeting held here this week.

With four panels covering more than 1,000 genes each, the product can get the same results for its targets as whole transcriptome profiling, with just a fifth of the number of reads per cell, 10x Staff Scientist Sarah Taylor told attendees of a lunchtime workshop sponsored by the single-cell, and now spatial, analysis company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.